CLINICAL_TRIALS trial_result · 2011-10-07

Clinical Trial Update: The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM) [Phase 1]

A Phase 1 clinical trial investigating the role of endogenous GLP-1 in Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED